Fund · ActivePassive International Equity ETF · measured from SEC filings
APIE holdings
APIE reports 548 holdings and behaves like 53.5 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-05-31. The fact sheet publishes the first number; this page computes the second, and traces it across 13 quarters of filings.
Measured concentration
as of 2026-05-31Read this figure with the following in mind
27.2% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 10.8
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 38 issuer countries.
What stands out
as of 2026-05-31APIE's largest investment is Taiwan Semiconductor Manufacturing Co Ltd at 11.88% of net assets. Tencent Holdings Ltd and ASML Holding NV follow; the three together are 16.05%. Ten companies are 23.91% of the fund; the other 538 share the rest. Among the 721 equity funds measured here, APIE behaves like 53.5 holdings against a median of 42.4 — close to the median. Across 13 quarterly filings APIE has become more concentrated: it behaved like 94.8 at 2023-05-31 and 53.5 at 2026-05-31. Between the 2026-02-28 and 2026-05-31 filings 38 positions were added and 23 dropped; 10.6% of the weight moved. the United States is the largest country at 22.31% of the portfolio, across 38 countries in the filing.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2023
13Between 2023-05-31 and 2026-05-31, APIE went from behaving like 94.8 equally weighted positions to 53.5 — 44% fewer, while its top ten went from 20.3% to 23.91% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-05-31 | 548 | 53.5 | 23.91% | 11.98% |
| 2026-02-28 | 533 | 65.6 | 23.3% | 10.13% |
| 2025-11-30 | 508 | 72.7 | 23.48% | 9% |
| 2025-08-31 | 516 | 87.9 | 21.13% | 7.91% |
| 2025-05-31 | 464 | 122.1 | 18.03% | 4.92% |
| 2025-02-28 | 392 | 113.3 | 19.36% | 5.34% |
| 2024-11-30 | 456 | 106 | 19.58% | 5.76% |
| 2024-08-31 | 417 | 100.5 | 20.86% | 5.4% |
Earlier filings (5 more, back to 2023-05-31)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-05-31 | 387 | 91.7 | 22.88% | 4.89% |
| 2024-02-29 | 295 | 89.7 | 22.93% | 4.27% |
| 2023-11-30 | 270 | 91.8 | 21.77% | 3.43% |
| 2023-08-31 | 275 | 94.1 | 21.2% | 2.71% |
| 2023-05-31 | 250 | 94.8 | 20.3% | 2.88% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
27.2% collateralAPIE's filing lists 549 positions including 27.2% of net assets in securities-lending cash collateral. Counted as filed the fund reads 10.8 effective holdings with a top ten of 50.04%; on its own investments — the figure above — it reads 53.5 with a top ten of 23.91%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-05-31The 15 largest of 548 positions in APIE's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: APIE.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | TSMC | 11.98% | 12.0% |
| 2 | Tencent Holdings Ltd | 2.32% | 14.3% |
| 3 | ASML Holding NV | 1.88% | 16.2% |
| 4 | Alibaba Group Holding Ltd | 1.74% | 17.9% |
| 5 | Roche Holding AG | 1.10% | 19.0% |
| 6 | AstraZeneca PLC | 1.09% | 20.1% |
| 7 | SAP SE | 1.04% | 21.2% |
| 8 | HSBC Holdings PLC | 0.96% | 22.1% |
| 9 | Novo Nordisk A/S | 0.91% | 23.0% |
| 10 | Novartis AG | 0.89% | 23.9% |
| 11 | Rolls-Royce Holdings PLC | 0.78% | 24.7% |
| 12 | Shell PLC | 0.77% | 25.5% |
| 13 | LVMH Moet Hennessy Louis Vuitt | 0.76% | 26.2% |
| 14 | Siemens AG | 0.76% | 27.0% |
| 15 | Allianz SE | 0.75% | 27.7% |
By country of issuer
as of 2026-05-31Share of APIE's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| United Kingdom | 14.03% |
| Japan | 13.10% |
| Taiwan | 12.99% |
| China | 7.44% |
| Germany | 7.34% |
| France | 7.31% |
| Switzerland | 5.60% |
| Netherlands° | 4.82% |
Returns the fund reported
2023-03 – 2026-05Monthly total returns from Item B.5 of APIE's own filings, 39 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: APIE.json · all funds.
Who borrows APIE's shares
2026-05-31The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-05-31, $277m was out to 19 borrowers, 26.51% of net assets. The largest, JP MORGAN SECURITIES LLC, held 14.3% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| JP MORGAN SECURITIES LLC | $40m | 14.3% |
| BARCLAYS CAPITAL INC. | $39m | 14.2% |
| GOLDMAN SACHS & CO. | $38m | 13.7% |
| CITIGROUP GLOBAL MARKETS INC. | $33m | 11.9% |
| MORGAN STANLEY & CO LLC | $22m | 8.0% |
Cash collateral reported against the loan: 27.20% of net assets, 102.6% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter APIE has filed, with each borrower: APIE.json · all funds.
Since the previous filing
2026-02-28 → 2026-05-31533 positions became 548: 38 added (0.6% of the fund at the later date), 23 dropped (0.8% at the earlier date). Half the sum of all weight changes, a turnover proxy: 10.6%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of APIE compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-02-28 | 2026-05-31 | Largest decreases | 2026-02-28 | 2026-05-31 |
|---|---|---|---|---|---|
| TSMC | 10.13% | 11.98% | Tencent Holdings Ltd | 2.72% | 2.32% |
| Novo Nordisk A/S | 0.67% | 0.91% | AstraZeneca PLC | 1.46% | 1.09% |
| ING Groep NV | 0.31% | 0.53% | Roche Holding AG | 1.42% | 1.10% |
| SoftBank Group Corp | 0.25% | 0.47% | HDFC Bank Ltd | 0.92% | 0.64% |
| Recruit Holdings Co Ltd | 0.30% | 0.49% | Banco Santander SA | 0.85% | 0.60% |
| Murata Manufacturing Co Ltd | 0.10% | 0.28% | Toyota Motor Corp | 0.93% | 0.69% |
New: Carnival Corp Ltd (0.26%), Compass Pathways Plc (0.03%), BioNTech SE (0.03%), ChipMOS Technologies Inc (0.02%), Abivax SA (0.02%), Cadeler A/S (0.02%). Gone: Grupo Cibest SA (0.24%), Carnival Corp (0.23%), Carnival PLC (0.09%), Ascendis Pharma A/S (0.06%), MBRF Global Foods Co SA (0.03%), Cosan SA (0.02%).
Asset categories and pricing
as of 2026-05-31| Asset category (as filed) | Share of investments |
|---|---|
| equity EC | 78.10% |
| short-term investment STIV | 21.88% |
| preferred equity EP | 0.02% |
100.0% of APIE is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of APIE (53.5). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| FEOE First Eagle Overseas Equity ETF | 76 | 52.3 | 30.39% | 2026-05-31 |
| OSCV Opus Small Cap Value ETF | 65 | 52.8 | 27.73% | 2026-07-31 |
| FLEU Franklin FTSE Eurozone ETF | 260 | 53.2 | 29.22% | 2026-06-30 |
| VONE Vanguard Russell 1000 Index Fund | 1,011 | 53.5 | 36.38% | 2026-05-31 |
| SCHK Schwab 1000 Index ETF | 989 | 53.5 | 36.24% | 2026-05-31 |
| XMHQ Invesco S&P MidCap Quality ETF | 81 | 54.1 | 31.61% | 2026-07-31 |
| IFRA iShares U.S. Infrastructure ETF | 164 | 54.4 | 32.36% | 2026-06-30 |
| CGGE Capital Group Global Equity ETF | 115 | 54.6 | 34.07% | 2026-05-31 |
| XMMO Invesco S&P MidCap Momentum ETF | 76 | 54.8 | 28.92% | 2026-07-31 |
| IYY iShares Dow Jones U.S. ETF | 967 | 54.8 | 35.04% | 2026-07-31 |
Essays that examine APIE
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.